Clinical trials

  • modified messenger ribonucleic acid encoding human propionyl-coenzyme a carboxylase alpha and beta subunits encapsulated into lipid nanoparticles for Propionic acidemia
  • BLINATUMOMAB for Acute lymphoblastic leukaemia
  • Rezafungin acetate for Chronic pulmonary aspergillosis
  • Adipose tissue-derived stem/stromal cells for Alzheimer's disease
  • PentixaTher radiolabelled with Lutetium-177 for Acute leukemia
  • ATEZOLIZUMAB for Malignant pleural mesothelioma
  • CEMIPLIMAB, FIANLIMAB for Malignant melanoma
  • TRETINOIN for Oligometastatic solid tumor
  • PREDNISONE for Giant cell arteritis (Horton's disease)
  • Omeprazole for Gastroesophageal reflux disease | Cow's milk protein allergy
  • Methylprednisolone (methylprednisolone hydrogen succinate / hemisuccinate / sodium succinate depending on product) for Focal cerebral arteriopathy | Ischemic stroke (childhood)
  • TISLELIZUMAB for Oral cavity squamous cell carcinoma